WO1998003510B1 - - Google Patents

Info

Publication number
WO1998003510B1
WO1998003510B1 PCT/US1997/013072 US9713072W WO9803510B1 WO 1998003510 B1 WO1998003510 B1 WO 1998003510B1 US 9713072 W US9713072 W US 9713072W WO 9803510 B1 WO9803510 B1 WO 9803510B1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
stereoisomeric forms
ome
isomers
dimethyl
Prior art date
Application number
PCT/US1997/013072
Other languages
English (en)
Other versions
WO1998003510A1 (fr
Filing date
Publication date
Priority to HU0102187A priority Critical patent/HU228962B1/hu
Priority to SI9720045A priority patent/SI9720045B/sl
Application filed filed Critical
Priority to IL15016397A priority patent/IL150163A0/xx
Priority to EP97936222A priority patent/EP0915880B1/fr
Priority to DK97936222T priority patent/DK0915880T3/da
Priority to JP50723398A priority patent/JP4704521B2/ja
Priority to BR9710544A priority patent/BR9710544A/pt
Priority to DE69738197T priority patent/DE69738197T2/de
Priority to IL12787197A priority patent/IL127871A0/xx
Priority to UA99010100A priority patent/UA73913C2/uk
Priority to HU0500549A priority patent/HU229024B1/hu
Priority to KR1019997000568A priority patent/KR100548853B1/ko
Priority to CA002259583A priority patent/CA2259583C/fr
Priority to AU38942/97A priority patent/AU747708B2/en
Priority to RO99-00078A priority patent/RO121272B1/ro
Priority to PL97331523A priority patent/PL195762B1/pl
Priority to SK97-99A priority patent/SK286461B6/sk
Priority to EEP199900019A priority patent/EE04316B1/xx
Priority to EA199900158A priority patent/EA004403B1/ru
Priority to NZ333777A priority patent/NZ333777A/en
Publication of WO1998003510A1 publication Critical patent/WO1998003510A1/fr
Publication of WO1998003510B1 publication Critical patent/WO1998003510B1/en
Priority to IL127871A priority patent/IL127871A/en
Priority to LVP-99-13A priority patent/LV12292B/en
Priority to NO19990264A priority patent/NO315610B3/no
Priority to AU23236/02A priority patent/AU773039C/en
Priority to IL150163A priority patent/IL150163A/en
Priority to IL164513A priority patent/IL164513A/en

Links

PCT/US1997/013072 1996-07-24 1997-07-23 Azolo triazines et pyrimidines WO1998003510A1 (fr)

Priority Applications (26)

Application Number Priority Date Filing Date Title
RO99-00078A RO121272B1 (ro) 1996-07-24 1997-07-23 Azolotriazine şi pirimidine
AU38942/97A AU747708B2 (en) 1996-07-24 1997-07-23 Azolo triazines and pyrimidines
IL15016397A IL150163A0 (en) 1996-07-24 1997-07-23 Azolo triazines and pyrimidines
SI9720045A SI9720045B (sl) 1996-07-24 1997-07-23 Azolo triazini in pirimidini
DK97936222T DK0915880T3 (da) 1996-07-24 1997-07-23 Azolotriaziner og pyrimidiner
JP50723398A JP4704521B2 (ja) 1996-07-24 1997-07-23 アゾロトリアジン類およびアゾロピリミジン類
BR9710544A BR9710544A (pt) 1996-07-24 1997-07-23 M-todo de tratamento composto e composi-Æo farmac-utica
DE69738197T DE69738197T2 (de) 1996-07-24 1997-07-23 Azolotriazine und pyrimidine
IL12787197A IL127871A0 (en) 1996-07-24 1997-07-23 Azolo triazines and pyrimidines
UA99010100A UA73913C2 (en) 1996-07-24 1997-07-23 Azolo triazines and pyrimidines
PL97331523A PL195762B1 (pl) 1996-07-24 1997-07-23 Związki [1,5-a]pirazolo-1,3,5-triazynowe, środek farmaceutyczny i zastosowanie związków [1,5-a]pirazolo-1,3,5-triazynowych do wytwarzania leku
KR1019997000568A KR100548853B1 (ko) 1996-07-24 1997-07-23 아졸로 트리아진 및 피리미딘
CA002259583A CA2259583C (fr) 1996-07-24 1997-07-23 Azolo triazines et pyrimidines
HU0102187A HU228962B1 (en) 1996-07-24 1997-07-23 Azolo triazines, pharmaceutical compositions containing them and use of the compounds
EP97936222A EP0915880B1 (fr) 1996-07-24 1997-07-23 Azolo triazines et pyrimidines
HU0500549A HU229024B1 (en) 1996-07-24 1997-07-23 Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof
SK97-99A SK286461B6 (sk) 1996-07-24 1997-07-23 [1,5-a]-Pyrazolo-1,3,5-triazíny, ich použitie a farmaceutické kompozície na ich báze
EEP199900019A EE04316B1 (et) 1996-07-24 1997-07-23 Asolotriasiinid ja -pürimidiinid, neid sisaldavadfarmatseutilised kompositsioonid ning nende kasutamine ravimite valmistamiseks
EA199900158A EA004403B1 (ru) 1996-07-24 1997-07-23 Производные пиразолотриазинов, фармацевтические композиции, содержащие их, способы лечения
NZ333777A NZ333777A (en) 1996-07-24 1997-07-23 (1,5-a) pyrazolo and triazole triazines and pyrimidines
IL127871A IL127871A (en) 1996-07-24 1998-12-30 PHARMACEUTICAL COMPOSITIONS CONTAINING CRF ANTAGONIST 3-ARYL-PYRAZOLO (AND 1,2,3-TRIAZOLO) [1,5-a]-1,3,5-TRIAZINE DERIVATIVES AND SOME NEW SUCH DERIVATIVES
LVP-99-13A LV12292B (en) 1996-07-24 1999-01-20 TRIANGLE AND PYRIMIDINES AZOL-DERIVATIVES
NO19990264A NO315610B3 (no) 1996-07-24 1999-01-21 Azolotriaziner og -pyrimidiner
AU23236/02A AU773039C (en) 1996-07-24 2002-03-12 Azolo triazines and pyrimidines
IL150163A IL150163A (en) 1996-07-24 2002-06-11 PHARMACEUTICAL COMPOSITIONS COMPRISING PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AND SOME NOVEL SUCH COMPOUNDS
IL164513A IL164513A (en) 1996-07-24 2004-10-12 Pyrazolopyrimidines, pharmaceutical compositions containing them and their use in the preparation of medicaments

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US68604796A 1996-07-24 1996-07-24
US2329096P 1996-07-24 1996-07-24
US08/686,047 1997-07-23
US60/023,290 1997-07-23

Publications (2)

Publication Number Publication Date
WO1998003510A1 WO1998003510A1 (fr) 1998-01-29
WO1998003510B1 true WO1998003510B1 (fr) 1998-04-02

Family

ID=26696934

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/013072 WO1998003510A1 (fr) 1996-07-24 1997-07-23 Azolo triazines et pyrimidines

Country Status (17)

Country Link
EP (2) EP0915880B1 (fr)
KR (1) KR100548853B1 (fr)
AR (1) AR007994A1 (fr)
AT (1) ATE375344T1 (fr)
AU (1) AU747708B2 (fr)
CZ (1) CZ2005613A3 (fr)
DE (1) DE69738197T2 (fr)
DK (1) DK0915880T3 (fr)
EA (1) EA006626B1 (fr)
ES (1) ES2294800T3 (fr)
HK (1) HK1052693A1 (fr)
HU (2) HU229024B1 (fr)
LV (1) LV12292B (fr)
PT (1) PT915880E (fr)
RO (1) RO121272B1 (fr)
TW (2) TWI238164B (fr)
WO (1) WO1998003510A1 (fr)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094782B1 (en) 1996-07-24 2006-08-22 Bristol-Myers Squibb Company Azolo triazines and pyrimidines
EP0970082A2 (fr) * 1997-02-18 2000-01-12 Neurocrine Biosciences, Inc. Antagonistes crf biazacycliques
NZ505079A (en) * 1998-01-28 2003-08-29 Du Pont Pharm Co Pyrazolotriazines and pyrazolopyrimidines useful as corticotropin releasing factor antagonists
US6613777B1 (en) 1998-03-06 2003-09-02 Chen Chen CRF antagonistic pyrazolo[4,3-b]pyridines
US6509338B1 (en) * 1998-06-22 2003-01-21 Bristol-Myers Squibb Company Pyrazolo[1,5-A]triazine corticotropin releasing factor antagonists
US6348466B1 (en) 1998-11-12 2002-02-19 Neurocrine Biosciences, Inc. CRF receptor antagonists and methods relating thereto
ES2180338T3 (es) 1998-11-12 2003-02-01 Neurocrine Biosciences Inc Antagonistas del receptor de crf y metodos relacionados.
WO2000059908A2 (fr) * 1999-04-06 2000-10-12 Du Pont Pharmaceuticals Company Pyrazolopyrimidines antagonistes de corticoliberine (crf)
AU4331500A (en) 1999-04-06 2000-10-23 Du Pont Pharmaceuticals Company Pyrazolotriazines as crf antagonists
US6432989B1 (en) 1999-08-27 2002-08-13 Pfizer Inc Use of CRF antagonists to treat circadian rhythm disorders
US6372743B1 (en) 1999-09-30 2002-04-16 Neurogen Corporation Certain alkylene diamine-substituted pyrazlo (1,5-a)-1,5-pyrimidines and pyrazolo (1,5-a) 1,3,5-triazines
ES2277855T3 (es) * 1999-09-30 2007-08-01 Neurogen Corporation Pirazolo-(1,5-a)-1,5-pirimidinas y pirazolo-(1,5-a)-1,3,5-triazinas amino sustituidas.
US6506762B1 (en) 1999-09-30 2003-01-14 Neurogen Corporation Certain alkylene diamine-substituted heterocycles
AU2001232271A1 (en) * 2000-02-14 2001-08-20 Japan Tobacco Inc. Preventives/remedies for postoperative stress
WO2002006286A2 (fr) * 2000-07-14 2002-01-24 Bristol-Myers Squibb Pharma Company Imidazo[1,2-a]pyrazines destinees au traitement d'affections neurologiques
CN1446316A (zh) * 2000-08-02 2003-10-01 玛洛普有限公司 基于下丘脑－垂体－肾上腺轴异常的非溃疡性消化不良的诊断和处置
RU2292347C2 (ru) 2001-03-13 2007-01-27 Бристоль-Мейерз Сквибб Фарма Компани 4-(2-БУТИЛАМИНО)-2,7-ДИМЕТИЛ-8-(2-МЕТИЛ-6-МЕТОКСИПИРИД-3-ИЛ)ПИРАЗОЛО-[1,5-а]-1,3,5-ТРИАЗИН, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ЕГО СОДЕРЖАЩАЯ, И ЕГО ПРИМЕНЕНИЕ
CA2446980A1 (fr) 2001-05-14 2002-11-21 Argyrios G. Arvanitis Pyrazinones, pyridines et pyrimidines substitues en tant que ligands de la corticoliberine
WO2003005969A2 (fr) 2001-07-12 2003-01-23 Bristol-Myers Squibb Pharma Company Tetrahydropurinones et leurs derives en tant que ligands du recepteur du facteur de liberation de corticotropine
US7276526B2 (en) 2001-07-13 2007-10-02 Bristol-Myers Squibb Pharma Company Substituted thiazoles and oxazoles as corticotropin releasing hormone ligands
US20030119831A1 (en) 2001-11-20 2003-06-26 Hartz Richard A. 3,7-dihydro-purine-2,6-dione derivatives as CRF receptor ligands
DE60301339T2 (de) 2002-03-07 2006-03-09 Smithkline Beecham Corp. Pyrazolopyrimidin- und pyrazolotriazinderivate und diese enthaltende pharmazeutische zubereitungen
ES2298513T3 (es) * 2002-04-26 2008-05-16 Eli Lilly And Company Derivados de tiazol como antagonistas del receptor de taquicinina.
FR2842809A1 (fr) * 2002-07-26 2004-01-30 Greenpharma Sas NOUVELLES PYRAZOLO[1,5-a]-1,3,5-TRIAZINES SUBSTITUEES ET LEURS ANALOGUES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, UTILISATION A TITRE DE MEDICAMENT ET PROCEDES POUR LEUR PREPARATION
FR2850653A1 (fr) * 2003-02-04 2004-08-06 Univ Pasteur Derives de pyrazolotriazine, procede de preparation et utilisations
US7329658B2 (en) 2003-02-06 2008-02-12 Pfizer Inc Cannabinoid receptor ligands and uses thereof
US7112585B2 (en) 2003-04-18 2006-09-26 Bristol-Myers Squibb Company Pyrimidine derivatives as corticotropin releasing factor inhibitors
US7030145B2 (en) 2003-04-18 2006-04-18 Bristol-Myers Squibb Company Pyridinyl derivatives for the treatment of depression
US7208596B2 (en) 2003-11-25 2007-04-24 Bristol-Myers Squibb Pharma Company Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof
US7153961B2 (en) 2003-11-25 2006-12-26 Bristol-Myers Squibb Pharma Co. Salt and crystalline form thereof of a corticotropin releasing factor receptor antagonist
WO2005063755A1 (fr) 2003-12-22 2005-07-14 Sb Pharmco Puerto Rico Inc Antagonistes du recepteur de crf et procedes correspondants
GB0519957D0 (en) 2005-09-30 2005-11-09 Sb Pharmco Inc Chemical compound
US20100216798A1 (en) * 2005-07-29 2010-08-26 Astellas Pharma Inc Fused heterocycles as lck inhibitors
CN101516886B (zh) 2006-09-20 2012-02-29 伊莱利利公司 噻吩吡唑并嘧啶化合物
PL2094709T3 (pl) * 2006-09-20 2011-02-28 Lilly Co Eli Tiazolopirazolopirymidyny jako antagoniści receptora crf1
JP5442449B2 (ja) 2006-12-22 2014-03-12 アステックス、セラピューティックス、リミテッド 新規化合物
AR064491A1 (es) 2006-12-22 2009-04-08 Astex Therapeutics Ltd Derivados de imidazo[1, 2-a]pirimidina, un proceso para su preparacion, una composicion farmaceutica que los comprende y su uso en el tratamiento de enfermedades mediadas por las quinasas fgfr.
EP2522351B1 (fr) * 2007-06-13 2017-09-06 Research Development Foundation Traitement et prévention de tauopathies et de l'amyloïdose de bêta-amyloïde en modulant la signalisation de récepteur CRF
GB0720041D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New Compounds
GB0720038D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New compounds
GB0810902D0 (en) 2008-06-13 2008-07-23 Astex Therapeutics Ltd New compounds
WO2010118207A1 (fr) 2009-04-09 2010-10-14 Schering Corporation Dérivés pyrazolo[1, 5-a]pyrimidine en tant qu'inhibiteurs de mtor
GB0906472D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
GB0906470D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
EP2264035A1 (fr) * 2009-06-04 2010-12-22 Merz Pharma GmbH & Co. KGaA B antagonistes de la glycine
EP2723746A1 (fr) 2011-06-22 2014-04-30 Vertex Pharmaceuticals Inc. Composés inhibiteurs de la kinase atr
PL2760453T3 (pl) 2011-09-30 2016-11-30 Makrocykliczne Inhibitory kinazy LRRK2
GB201210686D0 (en) 2012-06-15 2012-08-01 Holsboermaschmeyer Neurochemie Gmbh V1B receptor antagonist for use in the treatment of patients having an elevated AVP level and/or an elevated copeptin level
CA2891122C (fr) 2012-11-14 2021-07-20 The Johns Hopkins University Methodes et compositions pour le traitement de la schizophrenie
US8871754B2 (en) 2012-11-19 2014-10-28 Irm Llc Compounds and compositions for the treatment of parasitic diseases
CN105164124B (zh) 2012-11-19 2017-03-15 诺华股份有限公司 用于治疗寄生虫疾病的化合物和组合物
CN107501275B (zh) 2012-12-07 2019-11-22 沃泰克斯药物股份有限公司 可用作atr激酶抑制剂的化合物
WO2014144801A1 (fr) 2013-03-15 2014-09-18 Agenebio Inc. Procédés et compositions pour améliorer la fonction cognitive
WO2014144663A1 (fr) 2013-03-15 2014-09-18 The Johns Hopkins University Procédés et compositions pour améliorer la fonction cognitive
GB201310782D0 (en) 2013-06-17 2013-07-31 Max Planck Innovation Gmbh Method for predicting a treatment response to a CRHR1 antagonist and/or V1B antagonist in a patient with depressive and/or anxiety symptoms
RU2720408C2 (ru) 2013-12-06 2020-04-29 Вертекс Фармасьютикалз Инкорпорейтед Способ получения ингибиторов atr киназы (варианты)
AU2015271030B2 (en) 2014-06-05 2019-05-16 Vertex Pharmaceuticals Incorporated Radiolabelled derivatives of a 2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]- pyrazolo [1,5-a] pyrimidin-3-carboxamide compound useful as ATR kinase inhibitor, the preparation of said compound and different solid forms thereof
ES2733847T3 (es) 2014-06-17 2019-12-03 Vertex Pharma Método para tratar cáncer usando una combinación de inhibidores de CHK1 y ATR
WO2016042089A1 (fr) 2014-09-17 2016-03-24 Oncodesign S.A. Inhibiteurs macrocycliques de kinases lrrk2
AU2015342021B2 (en) 2014-11-03 2020-02-27 Bayer Pharma Aktiengesellschaft Piperidinylpyrazolopyrimidinones and their use
EA034167B8 (ru) 2015-05-22 2021-04-27 Эйджинбайо, Инк. Фармацевтические композиции леветирацетама пролонгированного высвобождения
WO2017059357A1 (fr) 2015-09-30 2017-04-06 Vertex Pharmaceuticals Incorporated Méthode de traitement du cancer utilisant une association d'agents endommageant l'adn et d'inhibiteurs de l'atr
US20210032253A1 (en) * 2018-02-06 2021-02-04 Jiangsu Hengrui Medicine Co., Ltd. Pyrazolo[1,5-a][1,3,5]triazine-2-amine derivative, preparation method therefor and medical use thereof
MX2021004769A (es) 2018-10-30 2021-08-24 Kronos Bio Inc Compuestos, composiciones, y metodos para modular la actividad cdk9.
WO2022036123A1 (fr) 2020-08-12 2022-02-17 Spruce Biosciences, Inc. Procédés et compositions pour traiter le syndrome des ovaires polykystiques
US11708372B2 (en) 2021-11-19 2023-07-25 Spruce Biosciences, Inc. Crystalline composition of tildacerfont and methods of use and preparation thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE786611A (fr) * 1971-08-16 1973-01-22 Int Chem & Nuclear Corp Nouveaux inhibiteurs de xanthine-oxydase et leur procede de preparatio
US3910907A (en) * 1973-07-09 1975-10-07 Icn Pharmaceuticals Pyrazolo(1,5-a)-1,3,5-triazines
US3995039A (en) * 1975-05-27 1976-11-30 Merck & Co., Inc. Pyrazolo [1,5-a] [1,3,5] triazines
JPS6157587A (ja) * 1984-08-29 1986-03-24 Shionogi & Co Ltd 縮合複素環誘導体および抗潰瘍剤
US4824834A (en) * 1986-10-31 1989-04-25 Otsuka Pharmaceutical Company, Limited Pyrazolotriazine compounds
DE3722072A1 (de) * 1987-07-01 1989-01-12 Schering Ag 6,7-dihydro-pyrazolo(1,5-a)(1,3,5) triazin-2-sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als mittel mit herbizider und pflanzenwuchsregulierender wirkung
JP2585462B2 (ja) * 1989-10-25 1997-02-26 株式会社大塚製薬工場 ピラゾロ［１，５―ａ］ピリミジン誘導体
US5420128A (en) * 1990-10-09 1995-05-30 Otsuka Pharmaceutical Co., Ltd. Pyrimidine derivatives, method of manufacturing the same, and androgen inhibitor
US5484760A (en) * 1990-12-31 1996-01-16 Monsanto Company Herbicide antidotes as safeners for reducing phytotoxicity resulting from synergistic interaction between herbicides and other pesticides
DE69130683T2 (de) * 1991-04-22 1999-05-06 Otsuka Pharma Co Ltd PYRAZOLO[1,5-a]PYRIMIDINDERIVATE UND SIE ENTHALTENDE ANTIINFLAMMATORISCHE MITTEL
US5356897A (en) * 1991-09-09 1994-10-18 Fujisawa Pharmaceutical Co., Ltd. 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines
US6765008B1 (en) * 1992-12-17 2004-07-20 Pfizer Inc Pyrrolopyrimidines as CRF antagonists
KR100315837B1 (ko) * 1994-06-21 2002-02-28 고리 히데아끼 피라졸로[1,5-a]피리미딘유도체
KR100256707B1 (ko) * 1995-05-12 2000-05-15 해피 페너 데아자푸린 유도체; 새로운 부류의 crf1 특이 리간드
EP0880523B1 (fr) * 1996-02-07 2006-08-16 Neurocrine Biosciences, Inc. Pyrazolopyrimidines en tant qu'antagonistes du recepteur de crf

Similar Documents

Publication Publication Date Title
WO1998003510B1 (fr)
EP0630898A4 (fr) Remede contre la thrombopenie.
CA2165819A1 (fr) Derives de dc-89
CA2079703A1 (fr) 9-amino-6-demethyl-6-desoxytetracyclines substituees en 7
CA2171275A1 (fr) Derives du stilbene et compositions pharmaceutiques qui en renferment
CA2079692A1 (fr) Amino-6-demethyl-6-desoxytetracyclines substituees en 7 et en 9
CA2219659A1 (fr) Derives de rapamycine
PL323152A1 (en) Derivatives of 1,3-propanodiole as biologically active compounds
CA2448602A1 (fr) Derives de pyrimidine, triazine et pyrazine, recepteurs du glutamate
AU629777B2 (en) Blocking agents of edrf effect or formation for the treatment of shock
CA2296665A1 (fr) Derives de la triazolo[4,5-d]pyrimidine en tant qu'agents antithrombotiques
CA2195964A1 (fr) Pesticides
CA2309350A1 (fr) Derives de purine et medicament les renfermant en tant qu'ingredient actif
NO975775L (no) Fremgangsmåte for fremstilling av forbindelser med antifungal aktivitet
CA2156078A1 (fr) Nouvelles imidazopyridines
NO307181B1 (no) Fremgangsmåte for fremstilling av N-[3(3-cyanopyrazol[1,5- a]pyrimidin-7-yl)fenyl]-N-etylacetamid
EP0686636A4 (fr) Derives tricycliques de benzazepine et benzothiazepine
ZA85327B (en) Therapeutic compounds
EP1008345A4 (fr) Agents anti-allergiques
EP0816366A4 (fr) Composes imidazothiazole
AU1925392A (en) A process for the preparation of n-(2,6-dichlorophenyl)-n-phenyl-n-(chloroacetyl)-amine
CA2193348A1 (fr) Derives d'alkyldiamines substituees et leur utilisation en tant qu'antagonistes de la tachykinine
CA2302412A1 (fr) Derives d'amino-alkylphenols et composes associes
EP0855398A4 (fr) Derives de sesquiterpene a activite antivirale
CA2080555A1 (fr) Derives de diphenylethane